4143 related articles for article (PubMed ID: 14615693)
1. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
2. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
3. [Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(4 Pt 1):306-12. PubMed ID: 14615700
[TBL] [Abstract][Full Text] [Related]
4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
5. Residual anxiety symptoms in depressed primary care patients.
McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
[TBL] [Abstract][Full Text] [Related]
6. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
9. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
Bech P; Lönn SL; Overø KF
J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
[TBL] [Abstract][Full Text] [Related]
11. Objective: remission of depression in primary care The Oreon Study.
Ansseau M; Demyttenaere K; Heyrman J; Migeotte A; Leyman S; Mignon A
Eur Neuropsychopharmacol; 2009 Mar; 19(3):169-76. PubMed ID: 19144502
[TBL] [Abstract][Full Text] [Related]
12. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
13. Time course of depression-symptom improvement during treatment with duloxetine.
Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
[TBL] [Abstract][Full Text] [Related]
14. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
15. Power laws in covariability of anxiety and depression among newly diagnosed patients with major depressive episode, panic disorder and controls.
Katerndahl DA
J Eval Clin Pract; 2009 Jun; 15(3):565-70. PubMed ID: 19522912
[TBL] [Abstract][Full Text] [Related]
16. [Depressive symptomatology and sleep apnea syndrome].
Pochat MD; Ferber C; Lemoine P
Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
18. A tetrachoric factor analysis validation of mixed depression.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):186-92. PubMed ID: 17804137
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
